Mary Ann Richardson, DrPH

ICRM Instructor & Founding Member

CURRICULUM VITAE


EDUCATION:

The U.T. Houston Health Science Center School of Public Health - DrPH, 1995, Health Promotion/Disease Prevention

The U.T.M.D. Anderson Cancer Center - Fellowship, 1994, Cancer Prevention

The U.T. Houston Health Science Center School of Public Health - MPH, 1991, Community Health Promotion/ Disease Prevention

Angelo State University - BA, 1969, English


Experienced independent investigator and research portfolio manager at the academic, government, for-profit, and non-profit organization levels; international focus to identify and validate innovative, low cost, non-toxic, novel healthcare solutions for chronic conditions such as cancer, HIV/AIDS, cardiovascular and neurologic disease.  Collaboration with industry, regulatory agencies, public and private clinical care settings.  Prior funded by the National Institutes of Health (NIH), the Department of Defense (DOD), and non-and for-profit organizations to develop and execute evaluations of mind-body, botanical, biopharmacologic, and bioelectromagnetic treatment modalities.  Managed large oncology portfolio at NIH and set research agendas.  Masters and doctorate in Public Health with primary emphasis on health promotion/disease prevention and secondary emphasis in epidemiologic and biostatistical methods.


POSITIONS:

2007 - Consultant

Dedicated to establishing strong collaborative networks among manufacturers/inventors, clinicians and research scientists, and visionary business groups to advance the science of ancient and emerging wisdom for health promotion, disease prevention, and wellness.  Expand knowledge by improving research development and investigation strategies with creative thinking, scientific rigor, and strategic investigational approaches. Assist businesses, individuals, and non-profit organizations with funding strategies for research programs, management and development of research programs, grant applications, protocol development, and regulatory approvals and enhance skills in scientific methodologies.
 

2003 - 2007 - Vice President of Investigations & Director of Research, National Foundation for Alternative Medicine, Washington DC

Developed framework for an international research and investigation program, directed field investigations, retrospective studies, and clinical research; managed research programs for a non-profit, internationally focused research organization founded by former congressman.

Principal Investigator of subcontract award and subsequently primary grant award from the DOD to identify and research complementary and integrative treatments with relevance to the military.  Developed, directed, and executed grants totaling over $1,000,000.

Developed research collaborations between industry and clinical researchers, advised industry regarding FDA regulatory requirements, including the Investigation Device Exemption (IDE) and Investigation New Drug (IND) application process.  Managed grant budgets, developed clinical protocols, and Institutional Review Board (IRB) approvals;  developed and monitored clinical research processes including creation of case report forms, data management forms, data bases and analysis, and reporting; directed PhD and Masters level staff, clinical research teams, and NFAM-Georgetown Internship program.


2000 - 2003 - Health Science Administrator/Program Officer, National Center for Complementary and Alternative Medicine (NCCAM), National Institutes of Health, Bethesda, MD

Managed large oncology portfolio (over $150 million) consisting of pilot study research (R21s), large-scale, more definitive clinical research (R01s), center grants in excess of $8 million each (P50s), supplements funded through the National Cancer Institute’s Center (NCI) mechanism (P-30s), large phase III clinical trials cofunded and cosponsored by NCI (U10s).  The portfolio primarily focused on biopharmacologic and herbal therapies, with the majority being clinical research (phase I, II and definitive phase III multi-center trials) of widely used agents and assessing survival, disease-free survival, neuroendocrine markers, psychosocial and physical functioning and quality of life endpoints.

Developed research initiatives and contracts, advised and guided potential grantees on the development of proposals and study design, represented applicants at the scientific peer review process, and presented funding plans to the NCCAM Advisory Council for approval.  Responsible for developing a critique of the scientific reviews, justifying special considerations to NCCAM Advisory Council, and guided researchers on the reapplication and revision processes.

Worked with the scientific review division, grants management team, and budget staff in the processing, administering, and managing of the research portfolio. In collaboration with budget staff, assisted in reconciling budget allocations and clarifying out-year commitments. Leveraged funds from other institutes and offices for contracts and research opportunities.

Responsible for tracking research trends and recommending areas of future opportunity, need, and expansion; conducted analyses and evaluations of program activities; recommended policy, program plans, and procedures.

Represented NCCAM at symposia and workshops, participated in planning committees for numerous scientific conferences, and organized and hosted state-of-the-science planning meetings and workshops with other federal agencies, including the Office of Dietary Supplements (NIH) and the Center for Food Safety and Nutrition (FDA); advised the Federal Trade Commission (FTC) staff regarding investigations.

Served as Executive Secretary for the Cancer Advisory Panel- for Complementary and Alternative Medicine (CAPCAM); worked with industry and clinicians to prepare and present evidenceto the CAPCAM for scientific review and consideration for future research programs; Editorial Board for the NCI Patient Database Query (PDQ).  Editorial Board and Clinical Advisory Board for private health care organizations. Scientific presentations and panel moderator for international and national conferences and symposia.
 

1999 - 2000 - Program Director, the University of Center for Alternative Medicine Research in Cancer; Co-Principal Investigator of UT-Cam U10 Center Grant; Assistant Professor, Behavioral Sciences, The University of Texas-Houston Health Science Center, Houston, Texas

Successfully competed for the center grant ($1.5 million), one of the first 10 funded by the National Institutes of Health to investigate and validate alternative therapies and the only one focused on cancer and co-funded by the National Cancer Institute.

Directed UT-CAM team that individually and collaboratively, included national and international cancer clinicians and researchers, health promotion and cancer prevention researchers, and CAM researchers; managed staff of over 10 researchers and research assistants; coordinated with administrative and budget staff, independent consultants, and clinical/research advisors.

Identified promising therapies and conducted state-of-the-science reviews of widely used biopharmacologic and herbal treatments, in collaboration with industry; provided resources for the cancer patients, the general public, and the oncology research community; Provided reliable information to advances the field, inform the public, and most importantly, impact the clinical treatment of cancer.  Pioneered the development of a website was the prototype and standard-bearer for information, acknowledged by the conventional community and NCI as a premier database, designated as an outstanding site by The University of Pennsylvania Cancer Center’s Oncolink, and featured as an outstanding resource for reliable information on CAM therapies by JAMA and TIME.  (Note:  The major cancer centers in the United States, including The University of Texas MD Anderson Cancer Center, have incorporated integrative, complementary medicine services, offer educational programs on CAM, and conduct rigorous research.)

Established a network of CAM and conventional practitioners, and executed clinical, pre-clinical and clinical studies as well as population-based, epidemiologic research.  With the goal of advancing therapies along the research continuum to increasingly more rigorous research designs, developed a field investigations and historical, retrospective research process, which are prerequisites for larger, more definitive trials. This approach to investigate and validate innovative therapies, became a model for the field and set a standard for further activities.

Worked with industry and academic institutions on product development and guided industry on the regulatory requirements for advancing products. Subsequently, several of these products were presented to the NIH/NCI CAPCAM advisory group for evaluation; and others obtained IND applications and advanced to clinical trials within the NIH intramural program, multi-center trials within the NCI cooperative research network, cooperative trials within the NCI centers program, or clinical trials internationally.

Cosponsored scientific conferences and workshops; planning committees; hosted state-of-the-science conferences; served on national and international special emphasis review panels; the complementary-alternative medicine group advisory board for the international Cochrane Collaboration Field Group.
 

1994 - 1996 Pre-Doctoral Fellow, Cancer Prevention (Funded by NCI), the University of Texas M.D. Anderson Cancer Center; Co-Principal Investigator (Funded by NIH), The University of Texas-Houston Health Science Center School of Public Health, Houston, Texas

Funded as an Independent investigator with overall responsibility for an NIH funded, new investigator grant (R21) to evaluate a behavioral and alternative treatment for women who were post treatment for breast cancer.  Awarded one of the first of 30 grants, from over 600 applicants, by the newly formed Office at Alternative Medicine at NIH. 

Established an inter-disciplinary team of clinicians, basic and behavioral scientists to plan and execute the research.  Responsible for managing the study team, accrual strategies and informed consent, oversee and scheduling the intervention delivery, database development data collection, analysis and reporting; budget management and accounting.
 

1989 - 1993 Project Coordinator/Research Associate, The Smoking Disclosure Project and Sustaining Women's Smoking Cessation Postpartum, The University of Texas Health Science Center, Houston, Texas

Responsible for overall conduct of a large, multi-center clinical research project funded by NIH to evaluate a large-scale behavioral change intervention at multiple private hospitals within Harris County, Texas.  Identity and evaluate the feasibility of sites to accrue and deliver the intervention, develop the training program; oversee the development and execution of intervention materials; coordinate with hospital study staff on study accrual and tracking data reports, data collection; prepare and oversee budgets, manage staff and research assistants; oversee database development, data entry, and data analysis; responsible for reporting on study progress, identifying and resolving problems with accrual, data collection, and/or participant follow-up; prepare progress and annual reports for the NIH funding agency.
 

1988 - 1989 Research Assistant, Effects of Mother-Child Joint Attention in Preterms, The University of Texas Medical Branch, Galveston, Texas

Overall project management responsible for study accrual, informed consent, scheduling and tracking follow-up systems; evaluation of study participants, review and coding of data to rate frequency and type of mother-child interactions; database creation, data entry and management, and supervision of support staff.
 

1987 - 1988 Research Assistant, Effects of Acculturation on Incidence of Breastfeeding Among Border Population, The University of Texas Medical Branch, Galveston, Texas

Responsible for data base development, data input, and data management; and reporting to the Program Director for this statewide epidemiologic, multi-disciplinary study.
 

1986 - 1987 Project Coordinator, Energy Expenditure Among 5 and 6 year olds, Family Health Project, The University of Texas Medical Branch, Galveston, Texas

Responsible for overall study coordination; identify sites for accrual, recruitment strategies and campaigns, scheduling of candidates for evaluation and informed consent; assist with study testing; and responsible for reimbursements and reporting.
 

1978 - 1983 Director, Corporate Communications, Texas Oilfield Supply, Houston, Texas

In collaboration with executive staff and advertising agency, developed corporate identity for organization, planned and developed print materials and newsletters; liaison for communications between corporate divisions and corporate headquarters.


1973-1978  Administrative Assistant, Union Gulf International, Houston, Texas.

Responsible for overall management of the business, including budgets, accounting, accounts payables.
 

1971-1973  Teacher, Houston Independent School District, Houston, Texas

English, secondary level, model city high school program.
 

GRANTS:

Co-Principal Investigator, Support/Imagery and Immune Function in Breast Cancer, funded by National Institutes of Health’s Office of Alternative Medicine, September, l993; 2 years $42,000

National Cancer Institute Predoctoral Fellowship, Cancer Prevention and Control Education Program, The University of Texas M.D. Anderson Cancer Center, February, l993; 2 years; funded at estimated $60,000.

Co-Principal Investigator/Program Director, U.T. Center for Alternative Medicine Research in Cancer (UT-CAM), funded by National Cancer Institute and National Institute of Health’s Office of Alternative Medicine, September, l995, 4.5 years, funded at an estimated $1.2 million.

Co-Investigator, Complementary and Alternative Medicine for the Military (MIL-CAM): Epidemiological Documentation Service (EDS), Department of Defense, September, 2004 (2 years), $172,100.

Principal Investigator, Complementary and Alternative Medicine for the Military (MIL-CAM): Epidemiological Documentation Service (EDS), Department of Defense, September, 2005 (2 years), $499,995.

Principal Investigator, Complementary and Alternative Medicine for the Military (MIL-CAM): Epidemiological Documentation Service (EDS), Department of Defense, September, 2007 (2 years), $375,000.


SCIENTIFIC REVIEW:

Scientific Reviewer, Complementary Therapies in Medicine, London, UK, 1997

Review Panel, Unconventional/Complementary Therapies in Breast Cancer, Grant Reviews, Canadian Breast Cancer Research Initiative, Toronto, Canada, January, l998.

Special Emphasis Panel, Grant Reviews, National Institute of Health Center for Scientific Review, December, l998.

Scientific Reviewer, Complementary and Alternative Methods, An American Cancer Society Consumer Book, August, 1999.

Scientific Reviewer, Bio-Behavioral Processes II Panel, Grant Reviews, National Institute of Health Center for Scientific Review, November, l999.

Scientific Abstract Reviewer, 7th Biennial Symposium on Minorities, The Medically Underserved & Cancer, Washington, DC, February 9, 2000.

Scientific Reviewer, Cochrane Gynecological Center Collaborative Review Group, Cochrane Collaboration, February, 2004.

Scientific Reviewer, Samueli Institute for Information Biology, Scientific Review Committee, April 29, 2004.

External Reviewer, Natural Health Products Research Program, Natural Health Products Directorate, Health Products and Food Branch, Health Canada, May 2, 2004.

External Reviewer, Randomized Controlled Trials Program, Canadian Institutes of Health Research, May 24, 2004.

Scientific Reviewer, Alternative Therapies in Health and Medicine

Scientific Reviewer: Journal of Clinical Oncology

Expert Reviewer, Cancer Information Service, Alternative Medicine Therapy Panel, Canadian Cancer Society

Scientific Reviewer: Nature Clinical Practice Oncology

Scientific Reviewer:  Journal of Complementary and Integrative Medicine


CONFERENCE COMMITTEES/SPECIAL ACTIVITIES:

Invited Participant, Canadian Breast Cancer Research Initiative Workshop, Research Methodologies for Unconventional Therapies, Vancouver, CANADA, October 4-6, 1996.

Planning Committee, Monitoring and Evaluation Approaches for Integrated Complementary and Alternative Medicine Cancer Practices, Sponsored by National Cancer Institute/Office of Alternative Therapies, Washington, DC, August, l997.

Advisory Committee, Conference Advisory Council, Comprehensive Cancer Care:  Integrating Complementary & Alternative Therapies, Washington, June, 1998, 1999, 2000.

Co-Chair, UT-CAM and McGill University Conference:  Evaluating the Evidence of Vitamin C in Cancer Treatment, Montreal, CANADA, June, 1999.

Advisory Committee:  Complementary and Alternative Medicine:  Modern Science and Ancient Wisdom, Houston, Texas, June, 1999.

Cancer Technical Expert Panel Chair, Evidence Based Practice Center- San Antonio Cochrane Collaborating Center, Systematic review: garlic and sylibum, October, 1999.

Panel Member, Special Panel on CAM, American Institute for Cancer Research, Washington, DC, February 21, 2000

Moderator and Organizing Committee, National Brain Tumor Foundation Workshop:  Setting a Research Agenda for CAM, Comprehensive Cancer Care 2000, Washington, DC, June 7, 2000.

NIH Listening Panel:  Review of Ephedra, sponsored by Office of Women's Health, Washington, DC, August 8-9, 2000.

Speaker/Participant- Invitational Workshop:  York University Center for Health Studies:  “Complementary & Alternative Medicine:  The Question of Appropriate Evidence Bases”, Toronto, CANADA, September 23-24, 2000.

Conference Organizer:  “IV Magnesium and Asthma:  Assessment of the State of the Science”, Washington, DC, September 27-28, 2000.

Advisory Committee:  From Tradition to Modernity:  Asian Therapies for Cancer:  A 1st International Conference, February 28-March 3, 2001.

Planning Committee, State-of-Science Conference on Symptom Management in Cancer: Pain, Depression, and Fatigue, Conference Sponsors: NCI, NCCAM, NIA, NIMH, NIHR, NINDS, FDA, July 15-16, 2001

Co-organizer, Planning Meeting for Antioxidants with Chemotherapy and Radiotherapy Workshop, Conference Sponsors: NCCAM, ODS, CF-SAN, July 30, 2001

NCCAM representative, PCSPES Roundtable, Urological Sciences Research Foundation, Santa Monica, CA October 15, 2001.

Planning Committee, Integrative Workshop on End-of-Life Research:  Focus on Older Populations, Sponsors: Fetzer, NINR, NIA, HRSA, AHRQ, NCI, NCCAM, Rockville MD, October 22-23, 2001.

NCCAM representative, Biological Mechanisms of Psychosocial Effects on Disease, Sponsors:  NIAMS, NIMH, NCI (BBRB; DCB; OCCAM), NIAIDS, NIA, CCAM, NIGMS, OBSSR, Bethesda, MD, February 28-March 1, 2002.

NCCAM representative, NIH End of Life Special Interest Group, June, 2000 - 2003.

NCCAM Roundtable representative, Annual Meeting of the Society of Behavioral Medicine, Washington, DC, April, 6, 2002.

NCCAM Roundtable representative, International Scientific Conference on CAM, Boston, MA, April 12-14, 2002.

Organizer, NCCAM Ad Hoc Working Group on Research on PC-SPES,  Bethesda, MD, August 12, 2002.

Invited Participant, Consultation with Research Funding Agencies, National Health Directorate, Health Canada, Ottawa, CANADA, November 3-4, 2003.

Planning Committee, Drug Information Association, Natural Health Products Special Interest Area Community “Promotion and Development of Botanicals with International Coordination”, Kolkata, INDIA, December 17- 18, 2004.
 

CONFERENCE COMMITTEES/SPECIAL ACTIVITIES:

Associate Editor, Cancer Prevention & Control, Area of Complementary/Unconventional Therapies, published by Canadian Medical Association. 1997-1999.

Editorial Board, Cancer Practice, published by the American Cancer Society, New York, 1999-2002.

Editorial Board, Physicians Data Query (PDQ) Adult Treatment Editorial Board, National Institutes of Health, National Cancer Institute, 2000-2002.

Editorial Board, Journal of Herbal Pharmacotherapy, Haworth Herbal Press, the Haworth Press, Inc. New York, 1999-Current.

Editorial Board, Alternative Health Practitioner: A Journal of Complementary and Integrative Health Care, Springer Publishing Company, New York.  1999 -current.

Editorial Board, Journal of Integrative and Complementary Medicine (JICM)- An international forum for evidence-based practices, Toronto, CANADA, 2003 –current.

Steering Committee and Program Committee, Place of Wellness, MD Anderson Cancer Center, 1998- 2000.

Advisory Board, Alternative Medicine Research Foundation of Texas, 1998- 2000.

Clinical Advisory Board, Haelth (Health Systems) LLC, New York, 1999-2003.

Executive Secretary, Cancer Advisory Panel for Complementary and Alternative Medicine (CAP-CAM), 2002.

Advisory Board, Complementary Medicine Field Group, The Cochrane Collaboration, 1999- 2003.

Operations Committee (National Society) Alternative Medicine, American Cancer Society, 2000 -2003

External Advisory Board, The University of Texas MD Anderson Cancer Center Integrative Medicine Center; 2003

Advisory Board, National Cancer Coalition, 2003- 2006

Expert Advisory Committee, National Health Products Directorate, Health Canada, 2004- 2006

Juror-  Roger Roger’s Award for Excellence CAM sponsored by Lotte and John Hecht Foundation, 2007-current (http://drrogersprize.org/index.php?content=jury&id=en)

Integrative Cancer Advisory Board Member, Embodi Works, 2010.

Scientific Committee, The Journal of Integrative Medicine for Peru, 2011.
 

PAST AFFILIATIONS and AWARDS

Cochrane Collaboration and Advisory Board, Complementary/Alternative Medicine Field Group

American Society of Clinical Oncology

International Biolectromagnetic Society

The Drug Information Society

Women in Biotech

Who's Who in America, 60th Diamond Edition, 2005


PUBLICATIONS:

Landry, S., Schmidt, M., Richardson, M.A. The effects of intraventricular hemorrhage on functional communication skills for preterm infants. Journal of Developmental and Behavioral Pediatrics, 10(6) 299-306, 1989.

Landry, S., Chapeski, L., Richardson, M.A., Palmer J., Hall, J. Social competence of children born prematurely: effects of medical complications and parent behaviors. Journal of Child Development, 61(5) 1605-116, 1990.

Richardson, M.A., Simons-Morton, B., Annegers, J.F. Perceived Barriers to Compliance with Antihypertensive Medication. Health Education Quarterly, 20, 4, 489-503, 1993.

Moye, L.A., Richardson, M.A., Post-White, J, Justice, B. Research methodology in psychoneuroimmunology: Rationale and design of the IMAGES-P (Imagery and group emotional support study-pilot) clinical trial; Alternative Therapies in Health and Medicine, 1(2), 34-37, l995.

Mullen, P.D., Richardson, M.A., Quinn, V., Ershoff, D. Postpartum Return to Smoking: Who is at Risk and When, American Journal of Health Promotion, 11(5), 323-330, 1997.

Richardson, M.A., Post-White, J., Grimm, E.A., Moye, L., Singletary, S.E., Justice, B., Coping, Life Attitudes, and Immune Response to Imagery and Group Support after Breast Cancer, Alternative Therapies in Health and Medicine, 3(5), 62-70, 1997.

Richardson, M.A., Post-White, J.; Singletary, S.E, Justice, B., Recruitment for Alternative Medicine Trials: Who Participates after Breast Cancer. Annals of Behavioral Medicine, 20:3, 190-198, 1998.

Pathak, S, Multani, AS, Ozen, M, Richardson, MA, Newman, RA.  Dolastatin-10 induces polyploidy, telomeric associations and apoptosis in a murine melanoma cell line, Oncology Reports, 5: 373-376, 1998.

Richardson, MA, Ramirez, T, Nanney, K, Singletary, SE, Alternative/Complementary Medicine: Implications for Patient-Provider Communications, Proceedings of ASCO, 18, 590a, May, l999.

Richardson, MA, Ramirez, T, Russell, NC, Moye, LA. Coley Toxins Immunotherapy: A Retrospective Review Alternative Therapies in Health and Medicine, 5 (3), 42-47, 1999.

Hoelscher Montgomery, DH, Richardson, MA, Complementary and Alternative Medical Therapies, Journal of Medicinal Food, 1 (4), 283-291, 1998-99.

Richardson, MA, Tamayo, C, Klein, A, Marcon, N, Rationale for Drug Development of Herbals in Oncology: Clinical, Industry, and Regulatory Perspectives, Drug Information Journal, 1999, 33, 1003-1010.

Tamayo, C, Richardson, MA, Diamond, S, Skoda, I, The Chemistry and Biological Activity of Herbs in Flor-Essence TM Herbal Tonic and Essiac TM, Phytotherapy Research, 2000, 13, 1-14.

Richardson, MA,  Research of Complementary/Alternative Medicine Therapies in Oncology:  Promising but Challenging, Journal of Clinical Oncology, 1999, 17, 11s (November Supplement), 38-43.

Richardson, MA, White, JD, Facilitating Research of Complementary/Alternative Medicine for Cancer:  A National Initiative, Cancer Practice, 2000, 8(1), 45-48.

Richardson, MA, Commentary, Use of Alternative Medicine by Women with Early-Stage Breast Cancer, New England Journal of Medicine, 340(22), 1733-1739, Breast Disease: A Year Book Quarterly, 10 (4), Jan-Mar 2000.

Richardson, MA, Commentary, Disclosing Complementary and Alternative Medicine Use in the Medical Encounter: a qualitative study in women with breast cancer. Journal of Family Practice, 1999, 48,6, 453-458,  Breast Disease:  A Year Book Quarterly, Volume 11(1), Apr-Jun 2000.

Richardson, MA, Sanders, T, Palmer, L, Greisinger, A, Singletary, S,  Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology, Journal of Clinical Oncology, 2000, 18, 2505-2514.

Richardson, MA, Sanders, T, Tamayo, C, Perez, C, Palmer, JL, Flor-Essence"℠Herbal Tonic Use in North America:  A Profile of General Consumers & Cancer Patients Herbal Tonic Use in North America, HerbalGram, 2000, 50, 40-46.

Hoffer, LJ, Tamayo, C, Richardson, MA.  Vitamin C as a Cancer Therapy:  An Overview, Journal of Orthomolecular Medicine, 2000, 15(4), 175-180.

Richardson, MA, Commentary, Prevalence of complementary therapy use by women with breast cancer:  a population-based survey.  European Journal of Cancer, 2000, 36, 1359-1364. Breast Disease: A Year Book Quarterly, 2000, 12 (1), 38-39.

Richardson, MA, Commentary,  A Comparison of Complementary Therapy Use between Breast Cancer Patients and Patients with Other Primary Tumor Sites.  American Journal of Surgery, 2000, 179, 407-411. Breast Disease: A Year Book Quarterly, 2001, 12 (1), 36-37.

Richardson, MA, Russell, NC, Sanders, T, Barrett, R, Salveson, C.  Assessment of Outcomes at Alternative Medicine Cancer Clinics: A Feasibility Study, Journal of Alternative & Complementary Medicine, 2001, 7(1), 19-32.

Richardson, MA.  Biopharmacologic and Herbal Therapies for Cancer: Research Update from NCCAM, Journal of Nutrition, 2001,131, 3037S-3040S.

Richardson, MA, Nanney, N, Masse, L, Sanders, T, Singletary, SE.  Discrepant Views of Oncologists & Cancer Patients on Complementary/Alternative Medicine, Alternative Therapies in Health and Medicine, 2001, 7(3), 109.

Richardson, MA, Ezzo, J, Vickers, A, Allen, C, Lao, L, Zhang, G, Ramirez, G.  Acupoint Stimulation for Chemotherapy Induced Nausea and Vomiting, Alternative Therapies in Health and Medicine, 2001, 7(3), S28.

Richardson, MA.  Complementary and Alternative Therapy Use in Gynecologic Oncology:  Implications for Clinical Practice, Gynecologic Oncology, 2002, 84, 360-362.

Weiger, WA, Smith, M, Boon, H, Richardson, MA, Kaptchuk, TJ, Eisenberg, DM,  Advising patients with cancer who seek complementary and alternative therapies for cancer, Annals of Internal Medicine, 2002, 137:889-903.

Richardson, MA and Straus, Stephen E.  Complementary and Alternative Medicine:  Opportunities and Challenges for Cancer Management and Research, Seminars in Oncology, 2002, 29(6):531-545.

Richardson, MA.   Discussing Complementary and Alternative Therapies at the End of Life,  In: The Cambridge Handbook of Advanced Cancer Care (Eds E. Bruera and M. Fisch) Cambridge University Press, 2003.

Tamayo, C and Richardson, MA, Vitamin C as a Cancer Treatment: State of the Science and Recommendations for Research, Journal of Alternative Therapies in Health and Medicine, 2003, 9(3), 94-102.

Richardson, MA, Mâsse, LC, Nanny,K, Sanders, C,  Discrepant Views of Oncologists and Cancer Patients on Complementary/Alternative Medicine, Journal of Supportive Care and Cancer, 2004, 12(11):797-804.

Ezzo, J, Vickers, A, Richardson, MA, Allen, C, Dibble, S, Issell, B, Lao, L, Pearl, M, Ramirez, G, Roscoe, J, Shen, J, Shivnan, J, Streitberger, K, Treish, I, Zhang, G.  Acupuncture-Point Stimulation for Chemotherapy-Induced Nausea and Vomiting, Journal of Clinical Oncology, 2005, 23 (28), 7188-7198.

Ezzo JM, Richardson MA, Vickers A, Allen C, Dibble SL, Issell BF, Lao L, Pearl M, Ramirez G, Roscoe JA, Shen J, Shivnan JC, Streitberger K, Treish I, Zhang G, Acupuncture-Point Stimulation for Chemotherapy-Induced Nausea and Vomiting, Cochrane Database, Issue 2, 2006.
 

ABSTRACTS ACCEPTED FOR POSTERS AND ORAL PRESENTATION:

Richardson, MA. The effects of perceived barriers on compliance with antihypertensive medication. Presented at the Society of Public Health Education Annual Meeting, Atlanta, Georgia, November, 1991.

Richardson, MA, Mullen, PD, DiClemente, CC., Banks, S, Taylor, W. Social support from partners: Implications for stress during pregnancy and postpartum. Presented at the Society of Behavioral Medicine Annual Meeting, March, 1992.

Richardson, MA, Mullen PD, DiClemente CC. Smoking during pregnancy and infant exposure postpartum: A man's perspective. Presented at the Society of Behavioral Medicine Annual Meeting, March 1993.

Richardson, MA, Justice, B, Post-White, J, Moye, LA, Singletary, S.E., Grimm, E.A Support/Imagery and Immune Function in Breast Cancer: Clinical Trial Design & Rationale, Presented at the Society of Behavioral Medicine, Boston, April, l994.

Richardson, MA Research methodology in psychoneuroimmunology: rationale, design, and clinical trial experience of IMAGES-P (Imagery and group emotional support study-pilot). Presented at the 2nd Annual NIH Conference on Complementary and Alternative Medicine Research Methodology Conference, Washington DC, April, 1995.

Richardson, MA, Singletary, SE, Alternative therapies for breast cancer: A clinical trial experience, Presented at the 123rd Annual Meeting of the American Public Health Association, San Diego, October, l995.

Richardson, MA, Post-White, J., Moye, LA., Justice, B., Grimm, EA, and Singletary, SE. Impact of support and imagery after breast cancer: Clinical implications. Presented at The 4th International Congress on Behavioral Medicine, Washington, DC, March, l996.

Mullen, PD.; DiClemente, C., Carbonari, J., Nicol, L., Richardson, MA, Taylor, W. Sockrider, M., Project Panda Maintenance of Prenatal Smoking Abstinence 6 Weeks Postpartum, Presented at The 4th International Congress on Behavioral Medicine, Washington, DC, March 13-16, l996.

Russell, NC, DeGuzman, M, Ramirez, T, Richardson, M., Alternative treatments for cancer:  Review of research and dissemination of findings, Poster presentation, Texas Public Health Association, Galveston, Texas, February, 1998.

Richardson MA, Russell, N, Ramirez, T, Alternative Treatments for Cancer:  Review of Research,  Poster presented at the Houston Dieticians Conference, Houston, September, 1998.

Richardson MA, Tamayo C, Ramirez T, Russell N.  Finding Evidence for Alternative Medicine in Cancer: A Systematic Review, Center for Alternative Medicine Research (UT-CAM), Poster presentation at The 6th International Cochrane Colloquium, University Of Maryland, Baltimore, Maryland, October 22 - 26, 1998.

Richardson, MA, Wargovich, M, Marcon, N, Tamayo, C, Evidence for Herbals and Nutritional Supplements for Cancer Therapy and Prevention, Panel presentation, 35th Annual Meeting of the Drug Information Association, Baltimore, June 28, 1999.

Rodriguez, MA, Cabanillas, F, Dang, NH, Grimm, EA, McLaughlin, P, McAda, N, Hagemeister, FB, Romaguera, J, Sarris, A, Younes, A, Richardson, MA, Lymphocyte Changes in Lymphoma Patients receiving Melatonin plus CHOP Chemotherapy, Poster Presented at the 36th Annual Meeting of the American Society of Clinical Oncology, New Orleans, May, 20-23, 2000.

Richardson, MA, Nanney, N, Masse, L, Sanders, T, Singletary, SE.  Discrepant Views of Oncologists & Cancer Patients onComplementary/Alternative Medicine, Presented at 2nd International Scientific Conference on Complementary, Alternative and Integrative Medicine Research,  San Francisco, May 17-19, 2001.

Richardson, MA, Ezzo, J, Vickers, A, Allen , C, Lao, L,  Zhang, G, Ramirez, G.  Acupoint Stimulation for Chemotherapy Induced Nausea and Vomiting,  Abstract , 2nd International Scientific Conference on Complementary, Alternative and Integrative Medicine Research, San Francisco, May 17-19, 2001.

Richardson, MA, Li, J,  Lin, CC, Marquina, N, Kiernan, J, Procyshen, T, Retrospective studies of the effect of bioelectromagnetic devices on pain, presented at the The Bioelectromagnetics Society and The European BioElectromagnetics Association, Dublin IRELAND, June 19-24, 2005.


INVITED PRESENTATIONS

Richardson, MA, Alternative Therapies and the Support/Imagery and Breast Cancer Trial, Seminar series 1st year medical students, Baylor College of Medicine, November, l993.

Richardson, MA, Alternative Therapies and the Support/Imagery and Breast Cancer Trial, Medical Breast Section, The M.D. Anderson Cancer Center, January, l994.

Richardson, MA, Overview of Alternative Therapies and Imagery/Support Study: Joan Gordon Center, February, l995.

Richardson, MA, Alternative Therapies and Medicine. Seminar series 1st year medical students, University of Texas-Houston Medical School, March, l995.

Richardson, MA, Evaluating Alternative Therapies for Cancer: Clinical Trial Experience. 2nd Annual Faculty Symposium, U.T. -Houston School of Public Health, October, l995.

Richardson, MA, The U.T. Alternative Medicine Center. Presentation at The Supportive Care Forum, The U.T. M.D. Anderson Cancer Center, January, l996.

Richardson, MA,  Alternative Medicine. Adult Learning Program Seminar Series, Houston, Texas, April, January, l996.

Richardson, M.A., Grimm, E.A., Wargovich, M., Singletary, S.E. Blending Alternative & Conventional Therapies: Mind-Body, Herbal, Nutrition. Presented at the M.D. Anderson Annual Patient Conference, Houston, Texas, September, l996.

Richardson, MA, Critical Analysis of Alternative Therapies for Complementary and Alternative Therapies for Cancer, University of Texas Medical Branch, School of Nursing, October, l996.

Richardson, MA, Critical Evaluation of Alternative Cancer: Implications for Public Health, Faculty Symposium, The University of Texas-Houston School of Public Health, November, l996.

Richardson, M.A., History of Alternative Medicine & Clinical Research in Alternative Cancer Therapy, Oregon Oncology Conference, Bend, Oregon, January, l997.

Richardson, MA, Alternative Therapies Update, Grand Rounds, Cancer Information Service, MD Anderson Cancer Center, March, l997.

Richardson, MA, Alternative Therapies Related to Breast Cancer, Joan Gordon Center, April9, l997.

Richardson, MA, State of the Science and Public Information on Alternative Cancer Therapies: What about efficacy and safety? Florida Nurses Oncology Association Annual Meeting, Pensacola, Florida, September, l997.

Richardson, MA, Facilitating Information and Evaluations: Alternative Therapies for Cancer, International Congress on Alternative Therapies, Washington DC, September, l997.

Richardson, MA, Complimentary Medicine: Massage Therapy, Therapeutic Touch, Herbs, Visualization, Aromatherapy, Hypnotherapy, Reiki:  Cancer Patient Education in the New Millennium- 3rd Annual Cancer Patient Education Conference, Detroit, Michigan, September, l997.

Richardson, MA, Alternative Care, Questions about cats claw, shark cartilage, ginseng and mega vitamins, Anderson Network: Partners in Knowledge, News in Cancer, M.D. Anderson Cancer Center, November, l997.

Richardson, MA, Research Studies in Alternative Medicine, When Your Patient Asks About Alternative Medicine, Northern California Cancer Center & Stanford University Annual Conference, Palo Alto, California, February, l998.

Richardson, MA, Overview of Alternative Medicine Research in Cancer, Symposium for Complementary & Alternative Medicine for Cancer Therapy- Supportive Mistletoe Therapy, Catholic Research Foundation for Gynecologic Cancer, Seoul, KOREA, March, l998.

Richardson, MA, Research in Alternative Therapies, Cruising the Tributaries of Oncology, North Idaho Cancer Center Annual Conference, Coeur d’Alene, Idaho, April, l998.

Richardson, MA,  Clinical Trials in Alternative Therapies, Benefits Healthcare Annual Cancer Care Conference, Great Falls, Montana, April, l998.

Richardson, MA.  Introduction to Integration, Harvard-MIT Conference on Alternative Medicine:  An Interaction Exploration of Non-Traditional Medicine, Cambridge, MA, April, l998.

Richardson, MA, Alternative Medicine and Breast Cancer, National Breast Cancer Coalition Fund, Washington, DC, May, 1998

Richardson, MA, Alternative/Complementary Medicine: Facilitating Information and Research at The University of Texas Medical Center, Rice University, Houston, Texas, May 1998.

Richardson, MA, Tamayo, C, Marcon, N, Klein, A, Rationale for drug development of herbal products for oncology:  Clinical, industry, and regulatory perspectives, Panel Presentation at 34th Annual Meeting of the Drug Information Association, Boston, MA, June, l998.

Richardson, MA, Issues in Research on Complementary and Alternative Therapies, Comprehensive Cancer Care:  Integrating Complementary and Alternative Therapies, Boston, MA, June, l998.

Richardson MA, Alternative Therapies for Cancer Prevention and Control, Summer Research Program 1998 Speaker Series, UT Houston Medical School, July, 1998.

Richardson MA, Cultural Beliefs Related to Healing: Alternative Approaches, UT-Houston Nursing School, July, 1998.

Richardson MA, The Potential Role of Biopharmacologics and Herbals in Oncology, The Health Show, Austin Texas, August, 1998.

Richardson MA, Alternative Medicine Research, Cancer Plants and Hope program, LSU Medical Center, New Orleans, LA, August, 1998.

Richardson MA, Scroggs, S, Herbs, Vitamins, and Nutrition: What Might Help & When?, MD Anderson Cancer Center:  Reunion of Hope – Living Fully with Cancer Patient Conference, Houston,  September, 1998.

Richardson MA, Overview ofUT-CAM Research.  Presented at the Advisory Group on Alternative and Complementary Therapies, American Cancer Society, Washington, DC, September, 1998.

Richardson MA, Research in Alternative & Complementary Treatments for Cancer Educational Forum on Lymphoma, The Lymphoma Research Foundation of America, Houston, October, 1998.

Richardson MA, Research in Alternative & Complementary Treatments for Cancer.  Pediatric Cooperative Oncology Group (PCOG), Cleveland, OH, November, 1998.

Richardson, MA. Overview of Complementary/Alternative Medicine (CAM) Activities, Presented at the Nutritional Oncology Adjuvant Therapy (NOAT) Annual Meeting, Columbus, Ohio, November, l998.

Richardson MA, Discovering the Science Behind Alternative Medicine, Cancer & Leukemia Group B Annual Conference (CAL-GAB), Fall, 1998.

Richardson MA, The Health Show: Longevity and Quality of Life, Disney’s Coronado Springs Resort, Florida, November, 1998.

Richardson MA, Alternative Therapy.  Anderson Network: Partners in Knowledge, News in Cancer (PIKNIC), M. D. Anderson Cancer Center, December 8, 1998.

Richardson, MA. Alternative Medicine: Is it Reality or a Dream?  Nutraceuticals/Functional Foods:  Sources, Extraction, Separation/Purification, Toxicology, Regulations, and Sensory Evaluation, Texas A&M University, College Station, Texas, February, l999.

Richardson, MA. Alternative Medicine: Implications for Clinical Practice and State-of-the-Science Symposia. Harvard Medical School, Boston, Massachusetts, February, 1999.

Richardson, MA.  Current Research and the pros/cons of combining conventional therapies with complementary therapies,  Presented at the North Center Cancer Treatment Group, Clinical Research Associate/Nurse Workshop, Mayo Clinic, Rochester, Minnesota, April 1999.

Richardson, MA.  Commonweal Symposium on New Direction in Cancer Care, San Francisco, California April, 1999.

Richardson, MA.  Alternative Medicine:  What Patients are Using and Implication for Health Care Providers, Texas Alliance for Patient Services, Houston, Texas, April, l999.

Richardson, MA. Complementary/Alternative Therapies: Expanding the research Agenda. Oncology Nursing Society 24th Annual Congress, Atlanta, Georgia, April, 1999.

Richardson, MA. Finding Evidence for Alternative Cancer Therapy.  International Conference on Integrative Medicine, Seattle, Washington, April, 1999.

Richardson, MA. Overview of Complementary/Alternative Medicine Activities, Presented at the Texas Medical Association Meeting, Dallas, Texas, May, 1999.

Richardson, MA.  State of the Current Cancer/CAM Research, ASCO/ACS Joint Symposium on Alternative and Complementary Therapies in Oncology Care.  35th Annual Meeting of the American Society of Clinical Oncology, Atlanta, May, l999

Richardson, MA.  Unconventional Methods of Cancer Treatment, Evidence Based Alternative Medicine Conference, Scottsdale, Arizona, May, 1999.

Richardson, MA,  Plenary Session: Complementary and Alternative Medicine (CAM) in Cancer Care:  A Progress Report, Comprehensive Cancer Care II, Washington, DC, June 7-11, 1999.

Richardson, MA,  Evidence Based Cancer Treatments, Complementary and Alternative Medicine:  Modern Science and Ancient Wisdom, Conference jointly Sponsored by UT-Houston/Memorial Hermann Healthcare System, June, l999.

Richardson, MA, Complementary and Alternative Cancer Therapies in the USA- Science and Politics: The Institute of CAM at the NIH.  The 10th Anniversary of the Bio-Med Klinic, Bad Bergzaber, GERMANY, September 4-5, 1999.

Richardson, MA and Chiang, J, Herbals and Acupuncture as Cancer Therapies, Living Fully with Cancer Patient Conference, Houston, September 24, 1999.

Richardson, MA, Alternative Medicine:  What Might Help but Won’t Hurt, MD Anderson Ovarian Cancer Research Program, Houston, October, 1999.

Richardson, MA,  Complementary Therapies, Moderator.  Issues in Prostate Cancer:  A Conference for Patients and Families, The Prostate Cancer Research Program, The University of Texas MD Anderson Cancer Center, October 29-30, 1999.

Richardson, MA, Alternative Medicine in the US: Update on Research Activities for Cancer, Symposium sponsored by Speyererhof Klinic/Deutsches Krebsforschungszentrum, Heidelberg, GERMANY, January, 2000

Richardson, MA, A Research Agenda for CAM and Cancer in the United States:  A Review of Evidence, Norwegian Cancer Society Symposium on CAM and Cancer, Oslo, Norway, March 24, 2000.

Richardson, MA, Implications of Alternative Medicine in the Care of Patients with Cancer, 13th Annual Virgil E. Thon Memorial Lectureship, Allegheny General Hospital, Pittsburgh, PA, April 13, 2000

Richardson, MA, Moderator, Integrating CAM into Comprehensive Cancer Centers, Comprehensive Cancer Care 2000, Washington, DC., June 9-12, 2000.

Richardson, MA, Complementary/Alternative Medicine – What Works”, ChemoRadiation Summit 2000, Yosemite, California, September 20-22, 2000.

Richardson, MA, Research in Complementary/Alternative Medicine, 78th Annual Fall Clinical Conference of the Kansas City Southwest Clinical Society, Kansas City, October 26, 2000.

Richardson, MA, Research Activities at NCCAM, 43rd Annual Conference and Convocation, American Medical Association Administrators, New Orleans, November 10, 2000.

Richardson, MA. Portfolio Update, Alternative Medicine: Implications for Clinical Practice and State-of-the-Science Symposia. Harvard Medical School, Boston, Massachusetts, February 11-14, 2001.

Richardson, MA. Importance of Evidence-Based Approach to Verifying Therapeutic Efficacy in Cancer Treatments, From Tradition to Modernity:  Asian Therapies for Cancer:  A 1st International Conference, New York, NY, February 28-March 3, 2001.

Richardson, MA,  Update on CAM Cancer Research by NCCAM.  Annual Cancer Centers Administrators Meeting, Tucson, AZ, March 22-24, 2001.

Richardson, MA.  Complementary Care.  Association of Cancer Executives 7th Annual Meeting, Washington, DC. , April 1-4, 2001.

Richardson, MA.  Research on Complementary/Alternative Medicine:  Update 2001.  Pacific West Cancer Fund and the National Cancer Coalition Conference, Miami, April 3-6, 2001.

Richardson, MA.  Research in Oncology at National Center for Complementary/Alternative Medicine.  Annual Cancer Center Administrators Forum, Tucson, April 22-24, 2001.

Richardson, MA.  Panel Moderator- Integrative Care at the Comprehensive Cancer Centers, ASCO/ACS/NCCAM Joint Symposium on Alternative and Complementary Therapies in Oncology Care.  37th Annual Meeting of the American Society of Clinical Oncology, San Francisco, May 15-17, 2001.

Richardson, MA. Update CAM Cancer Research at NCCAM, Presented at the Cancer Advisory Panel for Complementary Alternative Medicine (CAPCAM), Washington, DC, May 21, 2001.

Richardson, MA.  Research on CAM for Cancer in the United States:  Portfolio Update of the National Center for Complementary and Alternative Medicine at the NIH, International Congress on Herbal Medicines and Cancer, Florence, ITALY, June 8-9, 2001.

Richardson, MA.  An Update on CAM Research from NCCAM:  2nd Annual Conference on Pediatric Integrative Medicine:  Incorporating Evidence-Based Complementary and Alternative Therapies into Clinical Practice, Minnesota, June 27-July 1, 2001.

Richardson, MA,  Biopharmacologic and Herbal Therapies for Cancer – Research Update from NCCAM, 11th Annual Research Conference, American Institute for Cancer Research, Washington, DC, July 16-17, 2001.

Richardson, MA.  Research on CAM Cancer Activities: Update from NCCAM. Comprehensive Cancer Care 2001, Sponsored by the Center for Mind-Body Medicine, Washington, DC, October 16-21, 2001.

Richardson, MA.  Update on NCCAM Research for Cancer:  Focus on TCM, UCLA Center for East-West Medicine 6th Annual Conference, Improving Quality of Life:  Integrative Approaches to Pain and Cancer, Santa Monica, CA , November 2-4, 2001.

Richardson, MA, Research on Complementary and Alternative Medicine for Cancer:  Update from NCCAM, South Carolina Cancer Center, Columbia, S Carolina, January 23, 2002.

Richardson, MA. Update CAM Cancer Research at NCCAM, Presented at the Cancer Advisory Panel for Complementary Alternative Medicine (CAPCAM), Washington, DC, February 25, 2002.

Costello, B, Richardson, MA, Milner, J, Winters, B.  Antioxidants with Concurrent Cancer Therapies: To Use or Not to Use, Panel Presentation, 2002 Food and Nutrition Conference & Exhibition, Philadelphia, PA, October 19-22, 2002.

Richardson, MA, Overview of CAM, UC-San Francisco Mini-Cam Symposium, Keynote Speaker, San Francisco, CA, October 21-23, 2002.

Richardson, MA, Clinical Trials Design for Herbal Drugs, Presentations at the Drug Information Association Conference, “Latin American Herbal Medicines:  Harmonization of Regulatory and Drug Development”, Santiago, CHILE, September 1-2, 2003.

Richardson, MA, USA Funding Botanical Research Centers of Excellence, Presentations at the Drug Information Association Conference, “Latin American Herbal Medicines:  Harmonization of Regulatory and Drug Development”, Santiago, CHILE, September 1-2, 2003.

Richardson, MA. Issues and Challenges of Clinical Trial Design of Botanicals, Congreso Internacional de Medicinas Tradicional, Alternativa, y Complementaria, Quito, ECUDADOR, October20-24, 2003.

Richardson, MA, Moderator, Tibetan Medicine and Cancer Panel, 2nd International Congress on Tibetan Medicine, Washington, DC, November 5-8, 2003

Richardson, MA, Bridging Alternative and Conventional Medicine with Science, 5th International Congress on Complementary Therapies, Brazilian Association for Complementary Medicine, San Paulo, BRAZIL, May 6-8, 2005.

Richardson, MA, Bridging Alternative and Conventional Medicine with Science, First International Congress on Therapeutics, and International Congress on Phytomedicines and Natural Products, Caracus, VENEZUELA, October 2005.

Richardson, MA, Traditional Medical Approaches for HIV: Clinical Trials Issues & Outcomes Research, Global Summit, GHANA, March 2006